title: Metformin - a potentially effective drug for gestational diabetes mellitus: a systematic review and meta-analysis.
abstract: Metformin has been gradually used in the management of gestational diabetes mellitus (GDM). In order to prove the safety and efficacy of metformin used in pregnancy, we searched several databases for the reports of randomized trials comparing insulin and metformin used in GDM and conducted a meta-analysis. Data showed the rates of neonatal large for gestational age, cesarean section, neonatal respiratory distress and preterm birth were similar in both groups. Maternal glycated hemoglobin-% at gestational week 36-37 was significantly lower in metformin group, indicating good glycemic control of metformin. Maternal weight gain since enrollment to gestational week 36-37 was also lower in metformin group, making metformin worth using even when metformin is insufficient and supplementary insulin is needed. Data also showed that metformin significantly reduced the gestational hypertension complications in GDM patients, probably by reducing the endothelial activation and maternal inflammatory response of insulin resistance. Although metformin can cross the placenta, it is less likely to cause severe neonatal hypoglycemia compared with insulin since it neither stimulates pancreatic insulin release nor increases circulating insulin levels. According to most maternal and neonatal outcomes, metformin is an effective and safe alternative to insulin for GDM patients.
authors.affiliation: a Department of Obstetrics and Gynecology , Peking University First Hospital , Beijing , China.
authors.forename: Ye
authors.initials: Y
authors.lastname: Feng
authors.affiliation: a Department of Obstetrics and Gynecology , Peking University First Hospital , Beijing , China.
authors.forename: Huixia
authors.initials: H
authors.lastname: Yang
mesh_terms: D001724:Birth Weight; D016640:Diabetes, Gestational / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005865:Gestational Age; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents; D007328:Insulin / Q000627:therapeutic use; D007333:Insulin Resistance; D008431:Maternal-Fetal Exchange; D008687:Metformin / Q000009:adverse effects / Q000627:therapeutic use*; D011247:Pregnancy; D015430:Weight Gain
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin
keywords: Metformin; gestational diabetes mellitus; insulin; meta analysis